Screener
Niagen Bioscience NAGE Total Revenue
Total Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Niagen Bioscience in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Niagen Bioscience’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001386570-26-000030
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Sales, net | $31,474 | $30,481 |
| Cost of sales | 11,498 | 11,150 |
| Gross profit | 19,976 | 19,331 |
| Operating expenses: | ||
| Sales and marketing | 9,675 | 8,117 |
| Research and development | 1,481 | 1,258 |
| General and administrative | 7,244 | 5,184 |
| Total operating expenses | 18,400 | 14,559 |
Item 1. FINANCIAL STATEMENTS (unaudited)
FAQ
- What is Niagen Bioscience's total revenue?
- Niagen Bioscience (NAGE) reported total revenue of $31.47M in Q1 2026.
- How has Niagen Bioscience's total revenue changed year-over-year?
- Niagen Bioscience's total revenue increased by 3.3% year-over-year, from $30.48M to $31.47M.
- What is the long-term trend for Niagen Bioscience's total revenue?
- Over 3 years (2021 to 2025), Niagen Bioscience's total revenue has grown at a 24.3% compound annual growth rate (CAGR), from $67.45M to $129.42M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Niagen Bioscience's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude